COLLECTIONS
WORKFLOWS
CinCor Pharma is a US-based clinical-stage biopharmaceutical company focused on developing treatments for cardiovascular and cardio-renal diseases. The company was acquired by AstraZeneca in 2023, and its lead asset, baxdrostat, is a highly selective, oral small molecule inhibitor of aldosterone synthase currently in phase 2 of clinical development.
Focus Areas
Notable Investments
